Orion Corporation ("Orion"), a globally operating pharmaceutical company, and Invenra Inc., an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today ...

Along with the joint spinoff with a venture-capital firm, the Skokie-based carbon recycling company announced an interim CFO.

L'Oréal -backed biotech firm Debut has released an artificial intelligence (AI)-powered ingredient discovery platform aimed at the beauty industry. BeautyORB works to discover novel ingredients and ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of ...

In the competitive world of biotechnology, having a strong online presence is crucial for success. The right SEO agency can ...

A Platform For Animal Cell Technology West European biotechnology companies are getting together to establish a mechanism to ensure that they reap the benefits of European Community-funded research on ...

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform. | Neomorph is ...

Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics ...